As at 11:02 AM on 8/9/2010

The Share Price is: 27.50 GBX

Fusion IP - Commercialising University Intellectual Property

  • Home
  • About Fusion IP
    • Overview
    • Our IP Pipeline
    • The Fusion IP Model
    • Future Growth
  • Our partners
    • Overview
    • The University of Sheffield
    • Cardiff University
    • Finance Wales
    • IP Group
  • Portfolio
    • Overview
    • Medicine
    • Energy
    • Environment
    • Electrical
    • Engineering
    • Software
    • Other
  • Investor relations
    • Overview
    • Our Directors
    • Financials
    • Advisors
    • Corporate Governance
  • News

Home > News

Latest News

As you’d expect from a company in emerging technologies and world class IP, our companies generate considerable news. Full details of all RNS and portfolio company related announcements are detailed below:

  • Page:
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • Pfizer report demonstrates value of Simcyp virtual studies

    10 Jun 2008

    find out more
  • Biofusion interim results to 31 Jan 2008

    16 Apr 2008

    find out more
  • Simcyp launches new Paediatric Simulator

    14 Apr 2008

    find out more
  • Simcyp launches latest version of its ADME simulator platform

    02 Apr 2008

    find out more
  • Abcellute signs European distribution agreement with LGC

    28 Mar 2008

    find out more
  • Biofusion invests £265k in Asterion and raises shareholding to 43%

    26 Mar 2008

    find out more
  • Simcyp strengthens SAB

    17 Mar 2008

    find out more
  • Chronocort achieves positive results from Phase II study

    04 Mar 2008

    find out more
  • Launch of Demasq

    27 Feb 2008

    find out more
  • £600,000 investment into Phase Focus

    15 Feb 2008

    find out more
  • Page:
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • Environment
  • Medicine
  • Energy
  • Software
  • Electrical
  • Engineering

  • Home
  • Recruitment
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Site Map